Bacillus subtilis belongs to the family of gram-positive bacteria. It is an endospore-forming bacteria that spreads into the environment. Bacillus subtilis is usually found in the outer layer of soil. It is a rod shaped protective endospore that withstands extreme environmental conditions. It is used in various applications such as food and beverage processing. Furthermore, bacillus subtilis is a prominent bacteria in enzyme production that is used commercially by biotechnology companies.
Reproduced symmetrically or asymmetrically, bacillus subtilis generates a single endospore that can remain viable for decades and is resistant to unfavorable environmental conditions such as salinity, drought, radiation, extreme pH, and solvents. Increase in demand for nontoxic products in end-use industries such as food & beverages, industrial enzymes, agriculture, aquaculture, waste treatment, and pharmaceuticals is driving the market. However, adverse health effects and implantation of various regulations on the formation of bacillus subtilis are factors restraining the market.
Based on product type, the market can be segmented into <100 billion CFU/g, 100–300 billion CFU/g, and > 300 billion CFU/g. The <100 billion CGU/segment is expected to dominate the market owing to its rising consumption in aquatic animal feeding and feed additives for poultry. The 100–300 billion CFU/g is anticipated to expand at a fast pace during the forecast period. Increase in demand for high purity and enhanced quality of products for poultry and animal feed is driving the bacillus subtilis market.
In terms of application, the bacillus subtilis market can be divided into enzymes, pesticides, and others. Bacillus subtilis is widely consumed as industrial enzyme due to its enhanced properties. Owing to its nontoxic properties, bacillus subtilis pesticides are regarded as environmentally friendly, with little or no effect on humans, wildlife, pollinators, and most other beneficial insects.
In terms of end-use industry, the bacillus subtilis market can be split into pharmaceutical, food & beverages, aquaculture, waste treatment, agriculture, and others. Food & beverages is estimated to hold significant share of the bacillus subtilis market in the near future. Bacillus subtilis is different from conventional probiotics. It has a tough outer shell that can withstand harsh processing in fruit nectars, vegetable juices, smoothies, and frozen concoctions. It also stays viable within a wide range of pH conditions and does not germinate until it reaches the right environment. Additionally, the pharmaceutical industry is projected to expand at a rapid pace during the forecast period. Due to the rising demand of bacillus subtilis in the production of membrane proteins that are widely used in biomedical and biotechnology applications.
In terms of region, the bacillus subtilis market can be segregated into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Rise in demand for high purity bacillus subtilis in countries such as China, Japan, and India is significantly boosting the bacillus subtilis market in Asia Pacific. Latin America and Middle East & Africa also account for significant market share. This can be ascribed to the increase in demand for bacillus subtilis in key industries such as pharmaceutical and food & beverages in these regions. Rise in demand for nontoxic bacterial products and changing consumer preferences are projected to augment the demand for bacillus subtilis in the near future. Presence of prominent companies catering to end-use applications of bacillus subtilis is further driving the bacillus subtilis market in North America and Europe.
The bacillus subtilis market is highly competitive owing to the presence of major local players. Competition is also influenced by shift in demand and costs. Global players are adopting research and development strategies and engaging in technological advancements in order to produce unique products. Prominent companies operating in the bacillus subtilis market include Bayer, Aumgene Biosciences, Real IPM, Wuhan Kernel Bio-Technology Co., Ltd, BASF SE, Deerland Enzymes, Inc., and Lonza.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.